Endpoint News: A cardiovascular cell therapy player grabs $54M for a new beginning.
19/01/2021
Related news
29/06/2021
Ixaka Ltd and SomaLogic today announce a research collaboration to support the development of aptamer-based bispecific therapeutics. The collaboration will…
Read More
19/04/2021
Ixaka Ltd, an integrated cell and gene therapy company focused on the natural power of the body to cure disease,…
Read More
30/03/2021
Ixaka Ltd and Leiden University Medical Center (LUMC) today announce a research collaboration to expand understanding of Ixaka’s lead multi-cell…
Read More